BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
October 16, 2023 14:40 ET | BioAegis Therapeutics
Partnership supports execution of a large phase 2 global study to evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. NORTH BRUNSWICK, N.J., Oct....
ContraFect_LOGO_Web.jpg
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
October 16, 2023 07:30 ET | ContraFect Corporation
YONKERS, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
Global Antimicrobial Susceptibility Testing Market
Global Antimicrobial Susceptibility Testing Market 2023-2030: Unveiling Treatment Efficacy - Antimicrobial Susceptibility Testing Market Soars with Focus on Personalized Medicine
September 08, 2023 06:28 ET | Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report By Product, By Technique, By Application, By End-use, By Region,...
Global Market for Pneumonia Testing
Pneumonia Testing Industry Landscape 2023-2030: U.S. and China Leading the Way
July 27, 2023 07:18 ET | Research and Markets
Dublin, July 27, 2023 (GLOBE NEWSWIRE) -- The "Pneumonia Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market analysis for...
Global Mycoplasma Testing Market
Mycoplasma Testing Global Market to 2030: Rising Cell Culture Contamination Drives Growth
July 06, 2023 06:48 ET | Research and Markets
Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kits & Reagents), By Technology (PCR, ELISA, Direct Assay,...
22157.jpg
$43.1 Billion Point-of-Care Diagnostics Markets by Platform, Application, Sample Type, and End User - Global Forecast to 2030
June 01, 2023 09:23 ET | Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood...
Global Legionella Testing Market
Global Legionella Testing Market Analysis & Epidemiology Report, 2016-2022 & 2023-2031
May 26, 2023 07:53 ET | Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "Global Legionella Testing Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global legionella...
OpGen.jpg
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
May 15, 2023 16:15 ET | OpGen, Inc.
Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022Expanded U.S. growth opportunities with the Unyvero...
Global Infection Surveillance Solutions Market
Global Infection Surveillance Solutions Market 2023 - 2030: Increasing Adoption of Inorganic Growth Strategies Fuels the Sector
April 19, 2023 10:33 ET | Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User (Hospitals, Clinics, Ambulatory Surgical Center,...
OpGen.jpg
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
April 18, 2023 16:30 ET | OpGen, Inc.
Fisher Healthcare, a part of Thermo Fisher Scientific, will become the non-exclusive national laboratory distribution partner alongside OpGen, Inc.’s direct sales in the U.S. for the Unyvero A50...